DMD and Duchenne muscular dystrophy: Autologous stem cells harvested from DMD-affected patients include mesenchymal stem cells (MSC) and bone-marrow-derived cells, as well as myoblasts, mesoangioblasts, and cardiomyocytes, which undergo ex vivo genetic modifications to deliver functional dystrophin to the muscles affected by the disease [25,27,28,29].